Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Other Long-Term Liabilities : $15 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Other Long-Term Liabilities?

Tianjin Pharmaceutical Da Ren Tang Group's other long-term liabilities for the quarter that ended in Mar. 2024 was $15 Mil.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly other long-term liabilities declined from Sep. 2023 ($16 Mil) to Dec. 2023 ($15 Mil) and declined from Dec. 2023 ($15 Mil) to Mar. 2024 ($15 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual other long-term liabilities declined from Dec. 2021 ($18 Mil) to Dec. 2022 ($17 Mil) and declined from Dec. 2022 ($17 Mil) to Dec. 2023 ($15 Mil).

Tianjin Pharmaceutical Da Ren Tang Group Other Long-Term Liabilities Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Other Long-Term Liabilities Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Tianjin Pharmaceutical Da Ren Tang Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Tianjin Pharmaceutical Da Ren Tang Group Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SGX:T14) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

600329:China

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Headlines

No Headlines